Evidence map›Paper›PMID 31569396›Full record

ArticleCells2019

Inhibition of TOR in

Megan M Ford, Amanda L Smythers, Evan W McConnell, Sarah C Lowery, Derrick R J Kolling, Leslie M Hicks

Open access · goldAbstract read
In one paragraph

Article in Cells, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 24 citations in OpenAlex.

  1. Evolutionary conservation and metabolic significance of autophagy in algae.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2024
    Review
  2. Growing of the TOR world.Journal of experimental botany · 2022
    Article
  3. Article
  4. Article
  5. Role of Autophagy inPlants (Basel, Switzerland) · 2022
    Article
  6. Contributions of TOR Signaling on Photosynthesis.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Review
  9. Review
  10. A Tour of TOR Complex Signaling in Plants.Trends in biochemical sciences · 2021
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Megan M FordDepartment of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. megan.ford@unc.edu.ORCID 0000-0003-4468-1891
Amanda L SmythersDepartment of Chemistry, Marshall University, Huntington, WV 25755, USA. asmyther@email.unc.edu.ORCID 0000-0002-1552-6705
Evan W McConnellDepartment of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. evanmcc@live.unc.edu.ORCID 0000-0002-2295-3027
Sarah C LoweryDepartment of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. slowery@unc.edu.
Derrick R J KollingDepartment of Chemistry, Marshall University, Huntington, WV 25755, USA. kolling@marshall.edu.
Leslie M HicksDepartment of Chemistry, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA. lmhicks@unc.edu.
University of North Carolina at Chapel Hill · USMarshall University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The target of rapamycin (TOR) kinase is a master metabolic regulator with roles in nutritional sensing, protein translation, and autophagy. In

Indexed as

Chlamydomonas reinhardtiiChromatography, LiquidCysteineMorpholinesOxidation-ReductionPhotosynthesisPlant ProteinsProteomicsSignal TransductionTandem Mass SpectrometryTOR Serine-Threonine KinasesTriglycerides(5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanolCysteineMorpholinesPlant ProteinsTOR Serine-Threonine KinasesTriglyceridesChlamydomonas reinhardtiiphotosynthesisproteomicsredox signalingtarget of rapamycin

Identifiers

PMID31569396
PMCPMC6829209
OpenAlexW2975317338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.